FI103868B1 - Menetelmä farmaseuttisen koostumuksen valmistamiseksi fibriinin saostumisen tai kiinnikasvettumien estämiseksi - Google Patents

Menetelmä farmaseuttisen koostumuksen valmistamiseksi fibriinin saostumisen tai kiinnikasvettumien estämiseksi

Info

Publication number
FI103868B1
FI103868B1 FI896359A FI896359A FI103868B1 FI 103868 B1 FI103868 B1 FI 103868B1 FI 896359 A FI896359 A FI 896359A FI 896359 A FI896359 A FI 896359A FI 103868 B1 FI103868 B1 FI 103868B1
Authority
FI
Finland
Prior art keywords
adhesions
preparation
pharmaceutical composition
fibrin deposits
preventing fibrin
Prior art date
Application number
FI896359A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI103868B (fi
FI896359A0 (fi
Inventor
Marjorie A Mohler
Tue H Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI896359A0 publication Critical patent/FI896359A0/fi
Application granted granted Critical
Publication of FI103868B publication Critical patent/FI103868B/fi
Publication of FI103868B1 publication Critical patent/FI103868B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI896359A 1987-07-01 1989-12-29 Menetelmä farmaseuttisen koostumuksen valmistamiseksi fibriinin saostumisen tai kiinnikasvettumien estämiseksi FI103868B1 (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US6887287 1987-07-01
US12531987A 1987-11-25 1987-11-25
US12531987 1987-11-25
US21089588A 1988-06-24 1988-06-24
US21089588 1988-06-24
PCT/US1988/002194 WO1989000049A1 (en) 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
US8802194 1988-06-30

Publications (3)

Publication Number Publication Date
FI896359A0 FI896359A0 (fi) 1989-12-29
FI103868B FI103868B (fi) 1999-10-15
FI103868B1 true FI103868B1 (fi) 1999-10-15

Family

ID=27371438

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896359A FI103868B1 (fi) 1987-07-01 1989-12-29 Menetelmä farmaseuttisen koostumuksen valmistamiseksi fibriinin saostumisen tai kiinnikasvettumien estämiseksi

Country Status (14)

Country Link
EP (1) EP0297860B1 (no)
JP (1) JP2756131B2 (no)
KR (1) KR0131330B1 (no)
AU (1) AU621305B2 (no)
DE (1) DE3883645T2 (no)
DK (1) DK175597B1 (no)
FI (1) FI103868B1 (no)
IE (1) IE65658B1 (no)
IL (2) IL86933A (no)
NO (1) NO301748B1 (no)
NZ (1) NZ225260A (no)
PH (1) PH26527A (no)
PT (1) PT87886B (no)
WO (1) WO1989000049A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1995001292A1 (en) * 1993-07-02 1995-01-12 Quest International Bv. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
WO1999024062A1 (en) * 1997-11-07 1999-05-20 Chiron Corporation Novel igf-i composition and its use
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator

Also Published As

Publication number Publication date
NZ225260A (en) 1991-03-26
DE3883645T2 (de) 1994-02-03
KR0131330B1 (ko) 1998-04-17
NO895338D0 (no) 1989-12-29
WO1989000049A1 (en) 1989-01-12
AU621305B2 (en) 1992-03-12
PT87886B (pt) 1993-09-30
IE882023L (en) 1989-01-01
DK175597B1 (da) 2004-12-13
KR890701124A (ko) 1989-12-19
DE3883645D1 (de) 1993-10-07
FI103868B (fi) 1999-10-15
JP2756131B2 (ja) 1998-05-25
EP0297860B1 (en) 1993-09-01
DK675389D0 (da) 1989-12-29
NO301748B1 (no) 1997-12-08
PH26527A (en) 1992-08-07
IL86933A (en) 1993-07-08
DK675389A (da) 1990-02-28
JPH04502753A (ja) 1992-05-21
PT87886A (pt) 1989-06-30
AU1998588A (en) 1989-01-30
FI896359A0 (fi) 1989-12-29
IE65658B1 (en) 1995-11-15
NO895338L (no) 1990-02-28
EP0297860A1 (en) 1989-01-04
IL102625A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
FI885884A (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI893520A (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
FI98046B (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI891538A (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI900604A0 (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI882253A (fi) Menetelmä kefuroksiimiaksetiilikoostumuksen valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI900886A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI871492A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
FI883261A0 (fi) Menetelmä somatostatiinia sisältävän farmaseuttisen ainekoostumuksen valmistamiseksi
FI850654A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI892058A0 (fi) Fenolin valmistusmenetelmä
FI881303A (fi) Menetelmä ibuprofeenin valmistamiseksi
FI103868B1 (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi fibriinin saostumisen tai kiinnikasvettumien estämiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI873350A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI872769A (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
FI92065C (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
FI93119B (fi) Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä

Legal Events

Date Code Title Description
FG Patent granted

Owner name: GENENTECH, INC.